Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.423277625
Author: Trendlyne DVM scores

Mid-range Performer

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

39.52 0.43 (1.10%)

33.24% Gain from 52W Low

2.2M

XNAS Volume

XNAS 21 Jan, 2026 12:46 PM (EST)

Medium Financial Strength

44.4 / 100

Mid Valuation

46.8 / 100

Technically Neutral

58.1 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

1Yr Price target upside is 18%

9 analysts

Royalty Pharma PLC (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

33.24% Gain from 52W Low

SWOT Analysis

Royalty Pharma PLC (Class A) Live Price Chart